Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients

Status Completed

Clinical Trial Summary

The purpose of this trail is to evaluate the performance of Genetron TERT PCR Kit in Glioma patients using real-time PCR method.

Clinical Trial Description

This trial follows the principle of synchronous blinding. The enrolled cases are coded, and the enrolled samples are detected with the Genetron TERT PCR Kit and Sanger sequencing method. The results were determined independently according to the cutoff values or interpretation requirements provided by each method.Combined with the results of clinicopathological classification, the incidence of C228T and C250T mutations of TERT promoter genes in different subtypes was counted to evaluate the clinical application performance of the Genetron TERT PCR Kit. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05100602
Study type	Observational
Source	Genetron Health
Contact
Status	Completed
Phase
Start date	May 13, 2016
Completion date	December 8, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05557240` - Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients	N/A
Recruiting	`NCT05474573` - Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases	N/A
Recruiting	`NCT05485038` - General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas	N/A
Active, not recruiting	`NCT04547621` - HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM	Phase 1/Phase 2
Recruiting	`NCT05076513` - Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma	Early Phase 1
Completed	`NCT05806619` - Glioma: Biomolecular Aspects
Not yet recruiting	`NCT04562077` - Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome
Recruiting	`NCT06038760` - Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Completed	`NCT04497142` - Effect of Perampanel on Peritumoral Hyperexcitability in HGG	Phase 1/Phase 2
Recruiting	`NCT05500508` - Oral AMXT 1501 Dicaprate in Combination With IV DFMO	Phase 1/Phase 2
Active, not recruiting	`NCT05656053` - Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging
Recruiting	`NCT06196918` - Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients	N/A
Recruiting	`NCT05556486` - Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem
Recruiting	`NCT05406700` - Niraparib In Recurrent IDH 1/2 Gliomas	Early Phase 1
Recruiting	`NCT05773326` - Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG	Early Phase 1
Active, not recruiting	`NCT05063682` - The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients	Phase 1
Completed	`NCT05100173` - Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
Recruiting	`NCT05182905` - AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients	Early Phase 1
Recruiting	`NCT06381726` - Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life	N/A
Completed	`NCT03434262` - SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors	Phase 1